𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Thrombocytosis in patients with malignant pleural mesothelioma

✍ Scribed by Line Lisbeth Olesen; Henning Thorshauge


Publisher
John Wiley and Sons
Year
1988
Tongue
English
Weight
229 KB
Volume
62
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.

✦ Synopsis


Platelet counts were studied retrospectively in a series of 64 patients suspected of primary malignant pleural mesothelioma. Only platelet counts taken before chemotherapy and radiotherapy and surgery other than thoracocentesis were considered. Thirty-two patients had malignant pleural mesothelioma and 32 patients had other malignant disease in pleura. In both groups 34% had slightly elevated platelet counts. In a subgroup consisting of 18 patients with primary pulmonary adenocarcinoma 28% had thrombocytosis. The distribution of platelet counts did not differ in the diagnostic subgroups, and thrombocytosis had no differential diagnostic value in patients with malignant disease in any stage in the pleurae. The frequency of thromboembolic episodes was low.


πŸ“œ SIMILAR VOLUMES


Malignant pleural mesothelioma in pregna
✍ Patrick S. Ramsey; Diana R. Danilenko-Dixon; Kirk D. Ramin; Paul L. Ogburn Jr. πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 168 KB πŸ‘ 1 views

A 37-year-old pregnant woman presented at 18 weeks' gestation with unrelenting chest and shoulder pain, massive pleural effusion, and a large thoracic mass. Biopsy revealed an undifferentiated sarcomatous pleural mesothelioma. Malignant mesothelioma is a rare thoracic malignancy, which has not been

Serum hyaluronate in malignant pleural m
✍ Thierry Frebourg; Guy Lerebours; Bertrand Delpech; Daniel Benhamou; Philippe Ber πŸ“‚ Article πŸ“… 1987 πŸ› John Wiley and Sons 🌐 English βš– 339 KB πŸ‘ 2 views
A phase II study of gemcitabine in patie
✍ Jan P. van Meerbeeck; Paul Baas; Channa Debruyne; Harry J. Groen; Chris Manegold πŸ“‚ Article πŸ“… 1999 πŸ› John Wiley and Sons 🌐 English βš– 115 KB πŸ‘ 2 views

## BACKGROUND. Gemcitabine has shown activity in patients with less chemosensitive solid tumors. Phase II screening of novel drugs is an accepted method with which to investigate new therapies in malignant mesothelioma. The European Organization for Research and Treatment of Cancer-Lung Cancer Coo